Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
about
Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acidsMechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice.Role of malignant ascites on human mesothelial cells and their gene expression profilesMinireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.Carbohydrate recognition by boronolectins, small molecules, and lectins.Suppression of death receptor-mediated apoptosis by 1,25-dihydroxyvitamin D3 revealed by microarray analysis.The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity.The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal GrayWhole Reproductive System Non-Negative Matrix Factorization Mass Spectrometry Imaging of an Early-Stage Ovarian Cancer Mouse ModelGPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.Roles of lysophosphatidic acid in cardiovascular physiology and diseaseSimple enrichment and analysis of plasma lysophosphatidic acids.Lipid remodelling in human melanoma cells in response to UVA exposure.The GPR55 agonist lysophosphatidylinositol acts as an intracellular messenger and bidirectionally modulates Ca2+ -activated large-conductance K+ channels in endothelial cells.Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine.Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells.The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling.Saturated fatty acids as possible important metabolites for epithelial ovarian cancer based on the free and esterified fatty acid profiles determined by GC-MS analysis.Ultrasensitive and specific fluorescence detection of a cancer biomarker via nanomolar binding to a guanidinium-modified calixarene.Immunohistochemical Detection of Sphingosine-1-Phosphate and Sphingosine Kinase-1 in Human Tissue Samples and Cell Lines.Carbohydrate Biomarkers
P2860
Q24534268-53E7B77B-67C0-4529-9C0D-66BC1FD609E6Q30410474-43F2EED9-CFDA-491B-BD10-FDD2FC2DA024Q33559857-4AF1E858-C49C-450C-BE7D-D357FE8ACCCAQ33636763-BD661E37-8957-4D12-93A4-0504563756A7Q33691290-DD93E169-288D-412D-9494-FC6C84EE1F09Q35646945-9DE747D3-B15F-4E24-89E2-3B83E6CD9E4BQ35696499-1D5A1337-6B25-443A-B96F-500C23806448Q35897858-4DB5B78D-3310-4AC2-AD92-50E3B594095BQ36012373-E221B480-FB93-4623-8652-ED92EAFAC69CQ36398022-E1FA3FD0-AE95-47E0-9D60-E6EEEE4868DEQ36948520-08B22FC7-4C03-4612-B03C-05BF55AD50FFQ37593579-7596192B-B251-4694-9E01-6C5B37A31409Q38901714-0C166EB6-6095-4E7A-8997-62BC3E2BAF47Q39632662-E4F84BE6-2BC3-4718-982A-5EE5ADB80767Q41818510-7437BC37-37FC-4FF3-A89C-81D0EEC815AAQ41947077-B03299B7-2FC0-455D-A0B2-E1B57BBE0F0FQ47300195-96F56A4F-1B0B-4FBB-876B-40434184C063Q51113701-34B1B442-52C9-42EC-8551-3960C2877D32Q52575881-F511F811-A9D1-4730-B8A0-6E6EC4EC531BQ53256892-90307FF2-0585-476A-BE52-B4F9FF96EFCCQ57696972-26563D50-6004-4FE2-8316-C692A5E6A4D8
P2860
Fatty acid composition of lysophosphatidic acid and lysophosphatidylinositol in plasma from patients with ovarian cancer and other gynecological diseases.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Fatty acid composition of lyso ...... other gynecological diseases.
@en
Fatty acid composition of lyso ...... other gynecological diseases.
@nl
type
label
Fatty acid composition of lyso ...... other gynecological diseases.
@en
Fatty acid composition of lyso ...... other gynecological diseases.
@nl
prefLabel
Fatty acid composition of lyso ...... other gynecological diseases.
@en
Fatty acid composition of lyso ...... other gynecological diseases.
@nl
P2093
P356
P1433
P1476
Fatty acid composition of lyso ...... other gynecological diseases.
@en
P2093
Belinson J
Kennedy AW
P356
10.1006/GYNO.2001.6357
P407
P577
2001-10-01T00:00:00Z